Found 38 matching trials
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma PHASE2 This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Show More Location
Banner University Medical Center - Tucson
Learn More & Join Trial
Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma PHASE3 This is a randomized, open label, multicenter phase III trial comparing the...
Show More Location
Moores UC San Diego Cancer Center
Learn More & Join Trial
CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML) PHASE1 This is a single center, open-label phase 1/2 study to evaluate the safety ...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus PHASE1 This is a single-center, single-arm, open-label phase 1/2 study of CART19 i...
Show More Location
Children's Hospital of Philadelphia
Learn More & Join Trial
CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma PHASE1 The goal of this prospective, multicentric, single-arm, phase I/II clinical...
Show More Location
Hospital de Clínicas da UNICAMP
Learn More & Join Trial
A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma PHASE3 This trial will compare tisagenlecleucel to standard of care in adult parti...
Show More Status
Active Not Recruiting
Location
Novartis Investigative Site
Learn More & Join Trial
Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCR and 4-1BB Signaling Domains in Patients With Chemotherapy Resistant or Refractory Acute Lymphoblastic Leukemia PHASE2 This is a single center, single arm, open-label phase II study to determine...
Show More Location
Abramson Cancer Center of the University of Pennsylvania
Learn More & Join Trial
Study of Efficacy and Safety of Reinfusion of Tisagenlecleucel in Pediatric and Young Adult Patients With Acute Lymphoblastic Leukemia (ALL) PHASE2 This was a multi-center Phase II study investigating the efficacy and safet...
Show More Location
Childrens Hospital Los Angeles Divisionof Hematology/Oncology
Learn More & Join Trial
Study of Tisagenlecleucel in Combination With Ibrutinib in r/r Diffuse Large B-cell Lymphoma Patients PHASE1 A multi-center, open-label, phase Ib study to evaluate the safety and toler...
Show More Location
H Lee Moffitt Cancer Center and Research Institute
Learn More & Join Trial
Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients PHASE2 This was a single arm, open-label, multi-center, phase II study to determin...
Show More Location
Childrens Hospital Los Angeles SC
Learn More & Join Trial